Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.

Persson LJ, Aanerud M, Hardie JA, Miodini Nilsen R, Bakke PS, Eagan TM, Hiemstra PS.

Eur Respir J. 2017 Mar 15;49(3). pii: 1601328. doi: 10.1183/13993003.01328-2016. Print 2017 Mar.

PMID:
28298400
2.

Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.

Husebø GR, Grønseth R, Lerner L, Gyuris J, Hardie JA, Bakke PS, Eagan TM.

Eur Respir J. 2017 Mar 15;49(3). pii: 1601298. doi: 10.1183/13993003.01298-2016. Print 2017 Mar.

PMID:
28298399
3.

Complications and discomfort of bronchoscopy: a systematic review.

Leiten EO, Martinsen EM, Bakke PS, Eagan TM, Grønseth R.

Eur Clin Respir J. 2016 Nov 11;3:33324. doi: 10.3402/ecrj.v3.33324. eCollection 2016. Review.

4.

Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients.

Erdal M, Johannessen A, Eagan TM, Bakke P, Gulsvik A, Grønseth R.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 2;11:2099-108. doi: 10.2147/COPD.S108720. eCollection 2016.

5.

Change in pulmonary diffusion capacity in a general population sample over 9 years.

Storebø ML, Eagan TM, Eide GE, Gulsvik A, Thorsen E, Bakke PS.

Eur Clin Respir J. 2016 Sep 2;3:31265. doi: 10.3402/ecrj.v3.31265. eCollection 2016.

6.

Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients.

Eagan TM, Hardie JA, Jul-Larsen Å, Grydeland TB, Bakke PS, Cox RJ.

Respir Med. 2016 Jun;115:53-9. doi: 10.1016/j.rmed.2016.04.008. Epub 2016 Apr 20.

PMID:
27215504
7.

Macrophage migration inhibitory factor, a role in COPD.

Husebø GR, Bakke PS, Grønseth R, Hardie JA, Ueland T, Aukrust P, Eagan TM.

Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L1-7. doi: 10.1152/ajplung.00461.2015. Epub 2016 May 17.

PMID:
27190066
8.

Associations between obstructive lung disease and symptoms of obstructive sleep apnoea in a general population.

Jonassen TM, Eagan TM, Bjorvatn B, Lehmann S.

Clin Respir J. 2016 Mar 7. doi: 10.1111/crj.12472. [Epub ahead of print]

PMID:
26948980
9.

Participation in research bronchoscopy: a literature review.

Martinsen EM, Leiten EO, Bakke PS, Eagan TM, Grønseth R.

Eur Clin Respir J. 2016 Feb 3;3:29511. doi: 10.3402/ecrj.v3.29511. eCollection 2016. Review.

10.

Expert opinion of mediastinal lymph node positions from an intrabronchial view.

Roth K, Eagan T, Hardie J.

BMC Pulm Med. 2016 Jan 22;16:15. doi: 10.1186/s12890-016-0176-6.

11.

Peak oxygen uptake and breathing pattern in COPD patients--a four-year longitudinal study.

Frisk B, Hardie JA, Espehaug B, Strand LI, Moe-Nilssen R, Eagan TM, Bakke PS, Thorsen E.

BMC Pulm Med. 2015 Aug 19;15:93. doi: 10.1186/s12890-015-0095-y.

12.

Vitamin D, vitamin D binding protein, and longitudinal outcomes in COPD.

Persson LJ, Aanerud M, Hiemstra PS, Michelsen AE, Ueland T, Hardie JA, Aukrust P, Bakke PS, Eagan TM.

PLoS One. 2015 Mar 24;10(3):e0121622. doi: 10.1371/journal.pone.0121622. eCollection 2015.

13.

Productivity losses in chronic obstructive pulmonary disease: a population-based survey.

Erdal M, Johannessen A, Askildsen JE, Eagan T, Gulsvik A, Grønseth R.

BMJ Open Respir Res. 2014 Dec 1;1(1):e000049. doi: 10.1136/bmjresp-2014-000049. eCollection 2014. Erratum in: BMJ Open Respir Res. 2016;3(1):e000049corr1.

14.

Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.

Tangedal S, Aanerud M, Persson LJ, Brokstad KA, Bakke PS, Eagan TM.

Respir Res. 2014 Nov 15;15:138. doi: 10.1186/s12931-014-0138-6.

15.

Variability of within-breath reactance in COPD patients and its association with dyspnoea.

Aarli BB, Calverley PM, Jensen RL, Eagan TM, Bakke PS, Hardie JA.

Eur Respir J. 2015 Mar;45(3):625-34. doi: 10.1183/09031936.00051214. Epub 2014 Oct 30. Erratum in: Eur Respir J. 2017 Jan 25;49(1):.

16.

Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.

Husebø GR, Bakke PS, Aanerud M, Hardie JA, Ueland T, Grønseth R, Persson LJ, Aukrust P, Eagan TM.

PLoS One. 2014 Oct 3;9(10):e109721. doi: 10.1371/journal.pone.0109721. eCollection 2014.

17.

Serial Measurements of Arterial Oxygen Tension are Associated with Mortality in COPD.

Aanerud M, Saure EW, Benet M, Basagana X, Bakke PS, Garcia-Aymerich J, Eagan TM, Anto JM, Hardie JA.

COPD. 2015 Jun;12(3):287-94. doi: 10.3109/15412555.2014.948996. Epub 2014 Sep 17.

PMID:
25230156
18.

Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.

Olfert IM, Malek MH, Eagan TM, Wagner H, Wagner PD.

BMC Pulm Med. 2014 Jun 30;14:106. doi: 10.1186/1471-2466-14-106.

19.

Predictors for PaO2 and hypoxemic respiratory failure in COPD-A three-year follow-up.

Saure EW, Eagan TM, Jensen RL, Bakke PS, Johannessen A, Aanerud M, Nilsen RM, Thorsen E, Hardie JA.

COPD. 2014 Sep;11(5):531-8. doi: 10.3109/15412555.2014.898027. Epub 2014 May 15.

PMID:
24831555
20.

Airway obstruction, dynamic hyperinflation, and breathing pattern during incremental exercise in COPD patients.

Frisk B, Espehaug B, Hardie JA, Strand LI, Moe-Nilssen R, Eagan TM, Bakke PS, Thorsen E.

Physiol Rep. 2014 Feb 7;2(2):e00222. doi: 10.1002/phy2.222. eCollection 2014 Feb 1.

Supplemental Content

Loading ...
Support Center